课题基金 / 基金详情

Efficacy of Biomarker-Guided Intermittent Theta Burst Stimulation of the Left Dorsolateral vs Dorsomedial Prefrontal Cortex for Treatment Resistant Depression: A Step Toward Personalized Medicine

Efficacy of Biomarker-Guided Intermittent Theta Burst Stimulation of the Left Dorsolateral vs Dorsomedial Prefrontal Cortex for Treatment Resistant Depression: A Step Toward Personalized Medicine
生物标志物引导的左侧背外侧与背内侧前额皮质间歇性 Theta 爆发刺激治疗难治性抑郁症的疗效：迈向个性化医疗的一步
批准号：
454903
负责人：
Buchanan Derrick Matthew
金额：
$10.93万
依托单位：
Stanford University (California)
依托单位国家：
加拿大
项目类别：
Fellowship Programs
财政年份：
2021
资助国家：
加拿大
项目状态：
已结题
起止时间：
2021-10-01 至 2024-10-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=454903&lang=en
关键词：
Intermittent Theta Burst Stimulation Major Depression Disorder Repetitive Transcranial Magnetic Stimulation Treatment Resistant Depression

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Major depressive disorder is a leading cause of global disability, and approximately 30% of patients are resistant to conventional antidepressant pharmacotherapy. Intermittent theta burst stimulation is a non-pharmacological, non-invasive method for stimu
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金